SEARCH

SEARCH BY CITATION

References

  • 1
    D'Alessandro AM, Kalayoglu M, Sollinger HW et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157163.
  • 2
    Marsman WA, Wiesner RH, Rodriguez L et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 12461251.DOI: 10.1097/00007890-199611150-00011
  • 3
    Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105113.DOI: 10.1055/s-2001-12933
  • 4
    Salizzoni M, Franchello A, Zamboni F et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486493.DOI: 10.1007/s00147-003-0572-8
  • 5
    Tsoulfas G, Takahashi Y, Ganster RW et al. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation 2002; 74: 713.DOI: 10.1097/00007890-200207150-00003
  • 6
    Kellogg TA, Weiss CA, Johnston JW 3rd, Wasiluk KR, Dunn DL. Antiendotoxin agents share molecular homology within their lipopolysaccharide binding domains. J Surg Res 1999; 85: 136141.DOI: 10.1006/jsre.1999.5595
  • 7
    Van Goor H, Rosman C, Grond J et al. Translocation of bacteria and endotoxin in organ donors. Arch Surg 1994; 129: 10631066.
  • 8
    Pillay SP, Moore TD, Lynch SV et al. Endotoxin levels in adult liver donors. Aust N Z J Surg 1994; 64: 615617.
  • 9
    Miyata T, Todo S, Imventarza O et al. Endogenous endotoxemia during orthotopic liver transplantation in dogs. Transplant Proc 1989; 21: 38613862.
  • 10
    Albillos A, De La Hera A, Gonzalez M et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208217.DOI: 10.1053/jhep.2003.50038
  • 11
    Arai M, Mochida S, Ohno A, Arai S, Fujiwara K. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models. Hepatology 1998; 27: 123127.DOI: 10.1002/hep.510270120
  • 12
    Bhattacharjee AK, Opal SM, Palardy JE et al. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis. J Infect Dis 1994; 170: 622629.
  • 13
    Stephens R, Hamilton-Davies C. Update on antiendotoxin therapies. Hosp Med 2000; 61: 254258.
  • 14
    Pollack M, Hunter KW, inventors; Centocor, Inc., assignee. Monoclonal antibodies reactive with endotoxin core. US patent 5, 057, 598. 1991 October 15.
  • 15
    Priest BP, Brinson DN, Schroeder DA, Dunn DL. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide. Surgery 1989; 106: 147154.
  • 16
    Chavin KD, Yang S, Lin HZ et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999; 274: 56925700.
  • 17
    Fujiwara H, Kira K, Asakawa S et al. The application of the endotoxin test for globulin and other blood products. Yakugaku Zasshi 1999; 119: 451455.
  • 18
    Asakawa S, Fujiwara H, Naito S et al. Application of the Limulus test for practical quality control on endotoxin content in commercial human serum albumin (HSA) products. In comparison with the rabbit pyrogen test. Yakugaku Zasshi 1994; 114: 888893.
  • 19
    Naito S, Fujiwara H, Asakawa S et al. Application of the limulus amebocyte lysate test for measurement of endotoxin in the therapeutic human plasma protein fraction. Comparison with the rabbit pyrogen test. Yakugaku Zasshi 1992; 112: 551556.
  • 20
    Army Medical Museum (US). Luna LG (ed). Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, 3rd edn. New York : McGraw-Hill Co, 1968.
  • 21
    Preece A. A Manual for Histologic Technicians, 3rd edn. Boston : Carolina Press, 1985.
  • 22
    Neil DA, Hubscher SG. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection Transplantation 2001; 71: 15661572.DOI: 10.1097/00007890-200106150-00014
  • 23
    Means TK, Golenbock DT, Fenton MJ. The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000; 11: 219232.DOI: 10.1016/S1359-6101(00)00006-X
  • 24
    Lemasters JJ. V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 1999; 276: G1G6.
  • 25
    Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 12461257.DOI: 10.1016/S0016-5085(03)01209-5
  • 26
    Rudiger HA, Graf R, Clavien PA. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149159.
  • 27
    Hamada E, Nishida T, Uchiyama Y et al. Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatol 1999; 30: 807818.DOI: 10.1016/S0168-8278(99)80133-0
  • 28
    Levinsky NG. Organ donation by unrelated donors. N Engl J Med 2000; 343: 430432.DOI: 10.1056/NEJM200008103430610
  • 29
    Imber CJ, St Peter SD, Handa A, Friend PJ. Hepatic steatosis and its relationship to transplantation. Liver Transpl 2002; 8: 415423.DOI: 10.1053/jlts.2002.32275
  • 30
    Tekin K, Imber CJ, Atli M et al. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors. Transplantation 2004; 77: 411416.DOI: 10.1097/01.TP.0000110318.70879.20
  • 31
    Dunn DL, Priest BP, Condie RM. Protective capacity of polyclonal and monoclonal antibodies directed against endotoxin during experimental sepsis. Arch Surg 1988; 123: 13891393.
  • 32
    Burd RS, Battafarano RJ, Cody CS et al. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. Ann Surg 1993; 218: 250259.
  • 33
    Billiar TR, West MA, Hyland BJ et al. Murine monoclonal antibody directed against lipopolysaccharide (LPS) inhibits Kupffer cell activation by endotoxin in vitro. Prog Clin Biol Res 1988; 264: 367372.
  • 34
    Ziegler EJ, Fisher CJ Jr, Sprung CL et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991; 324: 429436.
  • 35
    Bud O, Golling M, Von Frankenberg M et al. Intramucosal pH and serum endotoxin concentrations as early predictive parameters for primary nonfunction after experimental liver transplantation. Transplant Proc 2000; 32: 25372538.
  • 36
    Llovet JM, Rodriguez-Iglesias P, Moitinho E et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol 1997; 26: 8895.DOI: 10.1016/S0168-8278(97)80014-1
  • 37
    Zipfel A, Schenk M, You MS et al. Endotoxemia in organ donors: graft function following liver transplantation. Transpl Int 2000; 13 (Suppl. 1): S286S287.DOI: 10.1007/s001470050343
  • 38
    McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 1994; 121: 15.
  • 39
    Ziegler EJ, McCutchan JA, Fierer J et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307: 12251230.
  • 40
    Pollack M, Raubitschek AA, Larrick JW. Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. J Clin Invest 1987; 79: 14211430.
  • 41
    Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 1993; 142: 367373.
  • 42
    McCord JM. Superoxide radical: controversies, contradictions, and paradoxes. Proc Soc Exp Biol Med 1995; 209: 112117.
  • 43
    McClain D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993; 13: 170182.
  • 44
    Deaciuc IV, D'ouza NB, De Villiers WJ et al. Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2001; 25: 935943.DOI: 10.1097/00000374-200106000-00020